EUS-Guided Choledocho-duodenostomy Using Lumen Apposing Stent Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Biliary Obstruction: A Multicenter Randomized Controlled Trial (DRA-MBO Trial)

医学 四分位间距 内镜逆行胰胆管造影术 随机对照试验 支架 不利影响 外科 内镜超声 内科学 胰腺炎
作者
Anthony Yuen Bun Teoh,Betrand Napoleon,Rastislav Kunda,Paolo Giorgio Arcidiacono,Pradermchai Kongkam,Alberto Larghi,Van der Merwe,Jeremies Jacques,Romain Legros,Ratanachu-Ek Thawee,Payal Saxena,Maridi Aerts,Lívia Archibugi,Shannon M. Chan,Fabien Fumex,Arthur J. Kaffes,Mark Tsz Wah,Nouredin Messaoudi,Gianenrico Rizzatti,Kelvin K. Ng
出处
期刊:Gastroenterology [Elsevier BV]
卷期号:165 (2): 473-482.e2 被引量:90
标识
DOI:10.1053/j.gastro.2023.04.016
摘要

Background & AimsSeveral studies have compared primary endoscopic ultrasound (EUS)-guided biliary drainage to endoscopic retrograde cholangiopancreatography (ERCP) with insertion of metal stents in unresectable malignant distal biliary obstruction (MDBO) and the results were conflicting. The aim of the current study was to compare the outcomes of the procedures in a large-scale study.MethodsThis was a multicenter international randomized controlled study. Consecutive patients admitted for obstructive jaundice due to unresectable MDBO were recruited. Patients were randomly allocated to receive EUS-guided choledocho-duodenostomy (ECDS) or ERCP for drainage. The primary outcome was the 1-year stent patency rate. Other outcomes included technical success, clinical success, adverse events, time to stent dysfunction, reintervention rates, and overall survival.ResultsBetween January 2017 and February 2021, 155 patients were recruited (ECDS 79, ERCP 76). There were no significant differences in 1-year stent patency rates (ECDS 91.1% vs ERCP 88.1%, P = .52). The ECDS group had significantly higher technical success (ECDS 96.2% vs ERCP 76.3%, P < .001), whereas clinical success was similar (ECDS 93.7% vs ERCP 90.8%, P = .559). The median (interquartile range) procedural time was significantly shorter in the ECDS group (ECDS 10 [5.75–18] vs ERCP 25 [14–40] minutes, P < .001). The rate of 30-day adverse events (P = 1) and 30-day mortality (P = .53) were similar.ConclusionBoth procedures could be options for primary biliary drainage in unresectable MDBO. ECDS was associated with higher technical success and shorter procedural time then ERCP. Primary ECDS may be preferred when difficult ERCPs are anticipated. This study was registered to Clinicaltrials.gov NCT03000855. Several studies have compared primary endoscopic ultrasound (EUS)-guided biliary drainage to endoscopic retrograde cholangiopancreatography (ERCP) with insertion of metal stents in unresectable malignant distal biliary obstruction (MDBO) and the results were conflicting. The aim of the current study was to compare the outcomes of the procedures in a large-scale study. This was a multicenter international randomized controlled study. Consecutive patients admitted for obstructive jaundice due to unresectable MDBO were recruited. Patients were randomly allocated to receive EUS-guided choledocho-duodenostomy (ECDS) or ERCP for drainage. The primary outcome was the 1-year stent patency rate. Other outcomes included technical success, clinical success, adverse events, time to stent dysfunction, reintervention rates, and overall survival. Between January 2017 and February 2021, 155 patients were recruited (ECDS 79, ERCP 76). There were no significant differences in 1-year stent patency rates (ECDS 91.1% vs ERCP 88.1%, P = .52). The ECDS group had significantly higher technical success (ECDS 96.2% vs ERCP 76.3%, P < .001), whereas clinical success was similar (ECDS 93.7% vs ERCP 90.8%, P = .559). The median (interquartile range) procedural time was significantly shorter in the ECDS group (ECDS 10 [5.75–18] vs ERCP 25 [14–40] minutes, P < .001). The rate of 30-day adverse events (P = 1) and 30-day mortality (P = .53) were similar. Both procedures could be options for primary biliary drainage in unresectable MDBO. ECDS was associated with higher technical success and shorter procedural time then ERCP. Primary ECDS may be preferred when difficult ERCPs are anticipated. This study was registered to Clinicaltrials.gov NCT03000855.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
知了完成签到 ,获得积分10
1秒前
为你钟情完成签到 ,获得积分10
2秒前
5秒前
6秒前
韭菜盒子发布了新的文献求助10
8秒前
潘特发布了新的文献求助10
11秒前
乌滴子完成签到,获得积分10
12秒前
量子星尘发布了新的文献求助10
13秒前
善学以致用应助韭菜盒子采纳,获得10
13秒前
jiaaniu完成签到 ,获得积分10
15秒前
清脆靳完成签到,获得积分10
16秒前
cp3xzh完成签到,获得积分10
16秒前
tian发布了新的文献求助10
18秒前
tian发布了新的文献求助10
18秒前
明理宛秋完成签到 ,获得积分10
19秒前
S月小小完成签到,获得积分10
23秒前
斯文的慕儿完成签到 ,获得积分10
30秒前
keen完成签到 ,获得积分10
30秒前
韭菜盒子完成签到,获得积分20
31秒前
潘特完成签到,获得积分10
32秒前
小彭友完成签到,获得积分10
43秒前
44秒前
josie完成签到 ,获得积分10
48秒前
llll完成签到 ,获得积分10
48秒前
量子星尘发布了新的文献求助10
48秒前
韭菜发布了新的文献求助10
48秒前
外向的斑马完成签到 ,获得积分10
49秒前
村长热爱美丽完成签到 ,获得积分10
51秒前
尹尹关注了科研通微信公众号
53秒前
呆呆完成签到 ,获得积分10
54秒前
xianyaoz完成签到 ,获得积分0
1分钟前
杨远杰完成签到,获得积分10
1分钟前
蓝桉完成签到 ,获得积分10
1分钟前
JuliaWang完成签到 ,获得积分10
1分钟前
无限的含羞草完成签到,获得积分10
1分钟前
八二力完成签到 ,获得积分10
1分钟前
韭菜发布了新的文献求助10
1分钟前
情怀应助科研通管家采纳,获得30
1分钟前
water应助科研通管家采纳,获得10
1分钟前
JamesPei应助科研通管家采纳,获得10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022